Medicines and borders
Carrying medicines to India and bringing them home: what the official texts say, and where they say nothing
This guide is for the weeks before you travel, if you take regular prescription medicines or expect to leave hospital with strong painkillers, sedatives or sleeping tablets. It gives general information from named official sources, not medical or legal advice.
The official texts on carrying medicines to India split in two. For a medicine containing a narcotic drug or psychotropic substance, India’s Department of Revenue says travellers may seek the Narcotics Commissioner’s permission well before they leave home. Under separate rules on drugs, India’s drug regulator describes a small allowance in a passenger’s own baggage, but no official text we read defines the average dose it is counted in, sets a prescription rule for ordinary medicines, or says how the allowance applies to any one medicine.
Your prescriber or pharmacist can tell you what each of your medicines contains, and India’s own lists say whether that ingredient is controlled there. Whether any of yours is controlled is the question the rest turns on. This page cannot answer it.
We found no Indian traveller guidance for taking a narcotic or psychotropic medicine out of the country. At home your own country’s rule applies, six of them are dated below, and for UK residents it isn’t the one written for visitors. The UK Home Office says its personal import policy does not apply to you if you are habitually resident in the UK and receiving medical treatment abroad, including where controlled drugs are dispensed to you abroad, and that to return to the UK with controlled drugs prescribed abroad you need to email its import and export licensing address.
Home Office via GOV.UK, Travelling with medicine containing controlled drugs; GOV.UK, Take medicine in or out of the UK, for the name of the team Checked 2026-10-02.
Read directly on 2 October 2026 through the GOV.UK content service. First published 16 August 2019; last changed 11 April 2023. The address given is dflu.ie@homeoffice.gov.uk. The page does not say whether a licence will be issued, how long it takes, what it costs, what quantity is allowed or when to email. Its 3-month allowance is for visitors whose medicines were prescribed in their own country of habitual residence. For medicines with no controlled drug in them it points to the MHRA, and we found no MHRA or GOV.UK page setting a traveller rule for those. An older GOV.UK answer page, Take medicine in or out of the UK, last updated 6 May 2016 and still live, names the team as the Drug and Firearms Licensing Unit (DFLU) and is worded more broadly: it says a UK resident prescribed medicine while abroad needs to contact that unit, without limiting this to controlled drugs. The 2023 page is the one relied on here.

Medically reviewed
Reviewed by Dr Gunjan Patel, MBBS, registered with the Gujarat Medical Council (G-65059). Reviewed for accuracy only. This page is general information, not advice about your own case, and Dr Gunjan Patel does not diagnose, prescribe or treat.
Two kinds of medicine
What a medicine contains decides which Indian rules apply to it.
Contains a narcotic drug or psychotropic substance
India’s Narcotic Drugs and Psychotropic Substances Act, the NDPS Act, controls these. Some familiar sedatives and painkillers are on its lists, which are set out below.
Contains neither
The NDPS texts are written for the first kind. For a medicine with neither ingredient in it, the official Indian texts we read say far less, and the next section sets out what they do say, including an allowance India’s drug regulator describes under its own rules.
The Act’s central rule carries a medical exception. Section 8(c) of India’s NDPS Act, except for medical or scientific purposes and in the manner and to the extent the Act and its rules provide, bars anyone from possessing, transporting, importing into India or exporting from India any narcotic drug or psychotropic substance, and where a licence, permit or authorisation is required, its terms must be met as well.
Narcotic Drugs and Psychotropic Substances Act 1985, section 8(c), read on India Code and in the Department of Revenue’s copy of the Act Checked 2026-10-02.
Read directly on 2 October 2026 through India Code’s data service, because the older India Code act pages were not loading, and matched against the Department of Revenue’s scanned copy. India Code’s copy of the Act says last updated 3 January 2022. This states the law’s general shape and says nothing about any one medicine.
Those lists are the authority on any one medicine, and this page only reports them. India’s NDPS Act lists alprazolam, clonazepam, diazepam, lorazepam and zolpidem as psychotropic substances, a 2018 notification added tramadol, and section 2 names morphine and codeine as opium derivatives, which makes them narcotic drugs, though notifications exclude some low-dose codeine combination products from their entries, and whether that takes such a product outside the Act for a traveller is not settled in what we read.
Read directly on 2 October 2026. India Code’s copy of the Act stops at schedule entry 110ZT and says last updated 3 January 2022; we also read schedule amendments of 2022, 2025 and 2026, but not two others, of November 2022 and February 2024. The 1985 notification is a heavily garbled scan. Some commonly prescribed medicines did not appear in what we read, which does not show they are outside the scheme. The lists themselves are the authority on any one drug, and your prescriber or pharmacist can tell you what your own medicine contains.
Start with whoever prescribed or dispensed each medicine. They can tell you what it contains, and India’s own lists say whether that ingredient is controlled there.
Arriving in India
What India’s official texts say about bringing medicines in.
The Department of Revenue has one page for travellers on this. India’s Department of Revenue says international travellers who wish to bring a narcotic drug or psychotropic substance may, well before leaving their own country, seek the Narcotics Commissioner’s permission to import it, sending the prescription and other relevant papers, and may then bring the drugs with them; substances in Schedule I of the NDPS Rules are prohibited in India. It names no form, fee, processing time or quantity, so if another website quotes one for this permission, ask which rule it comes from.
Department of Revenue, Ministry of Finance, Government of India, page for international travellers needing narcotic drugs or psychotropic substances for medical use Checked 2026-10-02.
Read directly from the live page on 2 October 2026. The page carries no date of its own; the site footer says last updated 22 September 2026. Its verb is may, and we have kept it. It names no form, fee, processing time or quantity, and says nothing about taking medicines out of India. Alprazolam, clonazepam, diazepam, lorazepam, zolpidem, tramadol, morphine and codeine did not appear in Schedule I in the copy of the Rules we read, whose schedule text predates amendments made from 2016 onwards, which we did not read in full. One sentence on the page, about medical use being permitted in all countries, reads as a drafting slip and is not relied on here.
The NDPS Rules describe import in terms of consignments. Rule 53 of India’s NDPS Rules, a general rule that does not mention travellers, prohibits importing narcotic drugs and psychotropic substances into India, or exporting them, except with an import certificate or export authorisation; the Department of Revenue says an import certificate from the Narcotics Commissioner is needed for each consignment. Nothing we read explains how a consignment process applies to one person carrying one prescription, so we haven’t guessed.
Narcotic Drugs and Psychotropic Substances Rules 1985, rule 53, Department of Revenue copy; Department of Revenue, import and export of narcotic drugs and psychotropic substances Checked 2026-10-02.
The Rules file is a 2017 scan, garbled in places, so each rule quoted from it on this page was cross-checked against an unofficial online law database. The scan’s footnote says rule 53 was substituted in 2015, and we found no later amendment to rules 53, 55, 58 or 66. A 2026 consolidated Act and Rules from the Central Bureau of Narcotics is image-only and could not be read. Nothing we read says whether the traveller permission is the same thing as an import certificate.
Once you are in India, a separate rule limits how much of a psychotropic substance one person may hold. 100 dosage units of a psychotropic substance at a time is the most one person may possess for personal medical use under Rule 66(2) of India’s NDPS Rules, or up to 300 for long-term use if a Registered Medical Practitioner has specifically prescribed it, and nothing we read says whether a prescriber outside India counts; the rule governs possession and says nothing about crossing India’s border.
Narcotic Drugs and Psychotropic Substances Rules 1985, rule 66(2), Department of Revenue copy Checked 2026-10-02.
The 100 unit proviso is legible in the Department of Revenue’s 2017 scan. The 300 unit proviso is only partly legible there, so its wording comes from an unofficial online law database, which credits it to amendments of 2006 and 2008; that is why this note is marked attributed. It covers psychotropic substances only, and narcotic drugs fall outside it.
Separately from the NDPS rules, India’s Drugs Rules, 1945, formerly the Drugs and Cosmetics Rules, include one rule written for passengers, Rule 36, and India’s drug regulator sets out its conditions in a notice. India’s drug regulator, the Central Drugs Standard Control Organisation, says in a notice that Rule 36 of India’s drug rules, a rule separate from the NDPS rules and written for drugs whose import section 10 of the Drugs and Cosmetics Act would otherwise bar, permits a passenger to import small quantities of drugs for their exclusive personal use as part of their bona fide baggage, not more than 100 average doses of any single drug, declared to customs if customs so direct; neither the notice nor the rule defines an average dose.
Both read directly on 2 October 2026. The notice PDF was created in May 2018, and its footer gives a start date of 19 February 2015. Rule 36 was read in the CDSCO consolidated Drugs Rules, 1945, as amended to 1 July 2024, where its baggage conditions match the 2016 text word for word; it lets the licensing authority sanction a larger quantity in an exceptional case. The same notice describes a separate Form 12A and 12B permit for drugs not permitted to be imported or marketed in India, and a 2024 amendment asks holders of that permit to report what they imported and used each year. No official text we read explains how the rule applies to a given medicine, or how it sits beside the NDPS permission for narcotic and psychotropic medicines, and this page reports what the regulator says without deciding either question.
No definition of an average dose
appears in any official Indian text we read on 2 October 2026, and none of them sets a prescription requirement for ordinary medicines carried as baggage or explains how the baggage allowance applies to a given medicine; India’s customs guide for travellers and its 2026 baggage rules and regulations do not mention medicines
This site’s own reading, on 2 October 2026, of the Department of Revenue pages, the NDPS Act and Rules, the Drugs and Cosmetics Act and Rules, the CDSCO notice on personal imports, the CBIC Guide for International Travellers and the 2026 customs baggage texts Checked 2026-10-02.
This is an absence finding from our own reading, and no authority made this statement. The CBIC Guide for International Travellers, updated as of February 2026, says it does not carry any legal authority and, for updated information on articles prohibited or restricted for import, points to the Customs Help Desk in the arrival hall. We could not read the Central Bureau of Narcotics’ 2026 consolidated Act and Rules, which is image-only. Absence from our reading is no proof that nothing exists.
The customs text comes last. India’s 2026 customs baggage regulations say arriving passengers carrying dutiable or prohibited goods must declare their baggage electronically before entering the Green Channel, and the declaration form lists narcotic drugs and psychotropic substances among prohibited imports; neither these regulations nor the 2026 Baggage Rules mention medicines.
Central Board of Indirect Taxes and Customs, Notification No. 15/2026-Customs (N.T.), Customs Baggage (Declaration and Processing) Regulations 2026 Checked 2026-10-02.
Read directly on 2 October 2026 from the PDF the CBIC portal serves. Dated 1 February 2026 and in force from 2 February 2026; the regulations apply to passengers arriving in India and leaving it. The Baggage Rules 2026, Notification No. 14/2026-Customs (N.T.), were also read. Neither text says whether a medicine brought in with the Narcotics Commissioner’s permission counts as prohibited goods to declare.
Two people hold the answers on your medicines: your prescriber, on what each one contains, and the Narcotics Commissioner, on permission for anything on India’s NDPS lists.
Leaving India
Taking a controlled medicine out of India.
Exports have a rule of their own. Rule 58 of India’s NDPS Rules, which is written for consignments and does not mention travellers, says no narcotic drug or psychotropic substance shall be exported out of India without an export authorisation for the consignment, on Form 5 and backed by the importing country’s import certificate; the Department of Revenue says one is needed from the Narcotics Commissioner for each consignment.
Narcotic Drugs and Psychotropic Substances Rules 1985, rule 58, Department of Revenue copy; Department of Revenue, import and export of narcotic drugs and psychotropic substances Checked 2026-10-02.
Rule 58 read in the 2017 scan and cross-checked as described for rule 53; the Department of Revenue page read directly on 2 October 2026, site footer dated 22 September 2026. A December 2025 amendment changed Forms 4A and 5 and none of the rules quoted on this page. Nothing we read says how, or whether, this applies to medicine in a traveller’s own baggage.
No traveller guidance found
for taking a medicine that contains a narcotic drug or psychotropic substance out of India, in the official Indian sources we searched on 2 October 2026; the Department of Revenue’s narcotics section has a traveller page for bringing such medicines in, and none for taking them out
This site’s own search, on 2 October 2026, of the Department of Revenue, Central Bureau of Narcotics, NCORD and Narcotics Control Bureau sites and the CBIC traveller texts Checked 2026-10-02.
This is an absence finding from our own search, and no authority made this statement. The Central Bureau of Narcotics’ 2026 consolidated Act and Rules is image-only and could not be read, and two Narcotics Control Bureau advisories about carrying medicines to another country were seen by title only. This page does not say that taking such a medicine out of India is allowed, or that it is prohibited, for a traveller.
That gap matters most to someone discharged with a medicine on the NDPS lists. We cannot close it, and this page does not say that leaving with such a medicine is allowed, or that it is prohibited.
Before discharge, ask the treating hospital to name each medicine in your discharge letter by its generic name and strength, and to say what it can put in writing about any that sit on India’s NDPS lists. The Department of Revenue names the Narcotics Commissioner as the authority for these medicines, so that office is the one to ask about your own case.
Discharge papers
Under full case management we chase the discharge papers. Permits and customs stay with you.
One task on the full case management list sits close to this page: chasing and checking every discharge document before you leave. Among those documents is a medicines reconciliation, which sets out what you were given, the equivalent where you live, and where there is no equivalent, for your own doctor and pharmacist to act on. The aftercare page describes the same work as your medicines mapped to what your country stocks.
The reconciliation is not a check on whether a medicine is controlled, or on whether it may cross a border. We do not apply for any permission or certificate on your behalf, and we do not deal with customs for you. Where an application is needed, it is yours, and the authority named on this page decides it. We do not diagnose, prescribe or treat.
A handover is only worth building if we were involved before and during treatment, so for care arranged another way we cannot put one together afterwards. The free 30 minute consultation is open either way, and if we cannot help, we say so.
Coming home
What each country says about bringing medicines home.
Each source was read on 2 October 2026, and where an official source and this page differ, the official source is right.
| Coming home to | What the official text says | What it leaves open | Dated |
|---|---|---|---|
| United Kingdom | Residents treated abroad fall outside the Home Office personal import policy. To return with controlled drugs prescribed abroad, email its import and export licensing address. | Outcome, timing, cost and quantity. No current traveller rule found for medicines without a controlled drug; an older 2016 GOV.UK page words the residents’ contact more broadly. | Changed 11 April 2023. Read 2 October 2026. |
| Ireland | Department of Health: visitors from outside the Schengen area may bring up to 3 months’ supply, and customs has the final say. Revenue: a reasonable amount for personal use, except for travellers from the Schengen Area, and medicines are among goods to declare when arriving from outside the EU. | Anything written for Irish residents coming home with controlled drugs. Whether connecting through the Schengen area on the way from India changes anything. | Updated 30 March 2023 and February 2026; Revenue traveller page published 22 December 2025. Read 2 October 2026. |
| Canada | From 1 October 2026: up to a 90-day supply of a controlled substance in Schedules 1 to 3 of the new Regulations (narcotics, controlled drugs and targeted substances such as benzodiazepines), declared, in a labelled container from a health care provider; Health Canada says prescribed by a practitioner. Until 30 September 2026: for narcotics and controlled drugs, a single course or 30 days, whichever was less. Other prescription drugs: Health Canada says residents generally may not bring them in, with discretion in listed situations for a single course or 90 days. | Whether a medicine prescribed and dispensed outside Canada qualifies, and whether planned treatment in India fits a listed situation. The border agency’s controlled substances memorandum (December 2018) still shows 30 days. | Published 17 December 2025, in force 1 October 2026. Health Canada pages 13 July and 1 October 2026; border agency memoranda December 2018 and July 2023. Read 2 October 2026. |
| Australia | Border Force: up to three months’ supply under the traveller exemption, with a letter or prescription in English, declared on arrival. | Any separate rule for residents coming home. | Updated 22 September 2024. Read 2 October 2026. |
| United States | Residents: no more than 50 dosage units combined of controlled substances obtained abroad, in original containers, declared. | Medicines with no controlled substance: the FDA says most personal importation is illegal, with discretion generally up to three months’ supply. A DEA flyer applies the 50-unit figure to foreign visitors; the regulation is the authority. | Text as of 30 September 2026. Read 2 October 2026. |
| United Arab Emirates | Emirates Drug Establishment: prior approval optional for visiting travellers, up to three months. FCDO and the UAE Embassy in the United States: approval needed in advance for controlled medication, and the FCDO says one month for listed medication. | How a UAE resident coming home in person is treated. The official sources disagree. | Establishment page undated. FCDO updated 24 July 2026. Read 2 October 2026. |
The United Kingdom row rests on the Home Office page cited in the key answer at the top of this page. The same page, writing about UK law, puts one task on the patient. The UK Home Office says that if you are prescribed medication you are responsible for checking whether it is subject to control, and that its guide should not be used in place of the law.
Home Office via GOV.UK, Travelling with medicine containing controlled drugs Checked 2026-10-02.
Read directly on 2 October 2026; last changed 11 April 2023. Written about UK law, and used here only for the general point that checking whether a prescribed medicine is controlled falls to the patient. The page adds that if in doubt you should take your own independent legal advice.
Up to 3 months’ supply
of prescription medicines for their own use is what Ireland’s Department of Health says visitors arriving from outside the Schengen area may bring, recommending original packaging and a prescription or a doctor’s or pharmacist’s letter, and saying Irish customs has the final say; its non-Schengen section speaks to visitors, and nothing on the page is written for Irish residents coming home
Read directly on 2 October 2026. The page shows published 1 April 2023 and last updated 30 March 2023. Its 30-day Article 75 certificate is for Schengen Area residents. We found no official Irish text written for residents returning with controlled drugs dispensed abroad; the page gives a Health Products Regulatory Authority address for questions about personal medication, enforcementcontrol@hpra.ie, inside its Schengen section.
90-day supply
of a controlled substance in Schedules 1 to 3 of Canada’s new Controlled Substances Regulations, which cover narcotics, controlled drugs and targeted substances such as benzodiazepines, is the most an individual entering Canada may import for their own use from 1 October 2026, declared at the port of entry and in a labelled container from a health care provider; until 30 September 2026, a class exemption for narcotics and controlled drugs allowed a single course of treatment or a 30-day supply, whichever was less; Health Canada’s traveller page adds that the medication must be prescribed by a practitioner, and neither text says whether a medicine prescribed and dispensed outside Canada qualifies
Read directly on 2 October 2026; published 17 December 2025, in force 1 October 2026, replacing the old class exemption, which Health Canada said would be revoked on that day. The 90-day limit is counted from the daily dose on the label, and Schedule 4, restricted drugs, is excluded. The text we read does not define health care provider. Health Canada’s traveller page, modified 1 October 2026 and read directly in a browser, gives the 90-day supply and says the label must name the practitioner who prescribed the medication; the Controlled Drugs and Substances Act defines a practitioner as someone registered under the laws of a Canadian province, and the page does not say whether it uses the word in that sense. The border agency’s controlled substances memorandum, D19-9-2, dated December 2018, still shows the 30-day rule, and the Justice Laws copy current to 21 September 2026 still marks section 225 as not in force.
Three months’ supply
is the most of a prescription medicine the Australian Border Force says may come in under the traveller exemption, carried in your accompanied baggage with a letter or copy of your prescription from your doctor, written in English, and declared on arrival, and says you should leave the medicine in its original packaging; it says most prescription medicines need no permit, even with a controlled substance in them
Australian Border Force, What medicines and substances can you bring in? Medicine for personal use Checked 2026-10-02.
Read live on 2 October 2026 from the data the page loads; the page shows last updated 22 September 2024. Neither the Border Force nor the Office of Drug Control draws a line between residents and visitors. The Office of Drug Control page, last updated 28 April 2026 and read as an archive copy of 4 June 2026 because the live site did not load, names morphine, oxycodone, methadone, methylphenidate and benzodiazepines among medicines the exemption covers, and asks for a prescription or doctor’s letter for any medicine containing codeine. Only the Border Force asks for English.
50 dosage units combined
of controlled substances obtained abroad for personal medical use is the most a United States resident may bring into the US under 21 CFR 1301.26, each in its original dispensed container and declared to a customs officer; the cap does not apply to controlled substances lawfully obtained in the US on a DEA registrant’s prescription
Code of Federal Regulations, 21 CFR 1301.26, via eCFR Checked 2026-10-02.
Read directly on 2 October 2026 from the text as of 30 September 2026; the section dates from 2004 and was last amended in 2016. It covers Schedules II to V. A DEA flyer from May 2026 applies the 50-unit figure to foreign visitors, which differs from the regulation; the regulation is the authority. For medicines that are not controlled, the FDA says most personal importation of drugs is illegal and describes discretion of generally up to a three-month supply in stated conditions; we read its page as an archive copy of 21 September 2026, matched to the live page through a summarising tool.
Ireland has a second official text worth reading beside the first. Ireland’s Revenue Commissioners say, in a manual for their officers, that a traveller passing through a customs point may carry a reasonable amount of medicines for personal use without an authorisation, except persons travelling from the Schengen Area, who need an Article 75 Certificate for certain controlled drugs, and that the allowance does not cover medicines sent by post or courier; Revenue’s traveller page lists medicines among goods you must declare to a customs officer when arriving from outside the EU.
Read directly from the PDF, document updated February 2026; the manual calls itself a guide only and says it is not legal advice. It gives no quantity and does not deal with Irish residents as such. The manual says the Article 75 Certificate covers controlled drugs in Schedules 2 and 3 of the Misuse of Drugs Regulations 2017, for at most 30 days’ supply. Revenue’s traveller page on prohibited or restricted goods from outside the EU, published 22 December 2025, was read live on 2 October 2026. Neither Irish source says whether connecting through the Schengen area on the way from India changes anything.
For Canadian residents, the agency that decides and the border agency word the same discretion differently, and the newer text is the narrower one. Health Canada’s guidance on bringing health products into Canada for personal use says that, generally, residents of Canada are not allowed to bring prescription drugs into Canada, and that it may permit a personal quantity, a 90-day supply or a single course of treatment, in listed situations, among them a resident returning with prescription drugs to continue a medical treatment that was required to be initiated while abroad. Canada’s border agency says, in a July 2023 memorandum, that Health Canada may use enforcement discretion to let a Canadian resident returning from abroad bring, on their person, a single course of treatment or a 90-day supply of a prescription drug, whichever is less, including drugs filled as part of medical care abroad; the memorandum leaves controlled substances to a separate memorandum and says residents may not import prescription drugs by mail or courier.
Health Canada, Bringing health products into Canada for personal use (GUI-0116) Checked 2026-10-02.
Read directly on 2 October 2026 in a browser at its primary address; the page was modified on 13 July 2026. It also says residents needing ongoing treatment with a prescription medication started abroad should speak with their doctor about getting a licensed product in Canada. Its wording is narrower than the 2023 border agency memorandum, and it is Health Canada that holds the discretion. Whether planned treatment in India counts as treatment required to be initiated while abroad is not stated.
Canada Border Services Agency, Memorandum D19-9-1, paragraphs 42 to 45 Checked 2026-10-02.
Read directly on 2 October 2026; dated July 2023. It describes discretion and gives no right. The memorandum asks for hospital, pharmacy or retail packaging or the original label, and it does not mention the new Controlled Substances Regulations.
Why the UAE row carries two answers
We have not settled this, and we do not pick a side. The regulator that now runs the service calls approval optional for visitors. The Emirates Drug Establishment calls prior approval optional for travellers visiting the UAE, allows narcotic and psychotropic medicines up to the patient’s need for a maximum of three months, and says the prescription and medical report must be carried and authenticated by the health authority following the patient; for UAE residents it says the application must be submitted through its electronic system, describes that residents’ service as importing through shipping companies, and does not say whether a resident carrying medicines home in person needs approval.
Emirates Drug Establishment, service page on permits to import medicines for personal use Checked 2026-10-02.
Read directly on 2 October 2026; the page carries no date. For residents, the page says the application must be submitted electronically, but it describes the residents’ service as importing medicines through shipping companies and does not say whether a resident carrying medicines home in person needs approval. A Ministry of Health and Prevention page, read as an archive copy of 10 January 2026, said the service would move to the Establishment on 29 December 2025 and that travellers without prior approval must declare such medicines on arrival; the live Establishment page has no such sentence. The Establishment’s list of controlled and semi-controlled medicines, linked from the page, gives for medicines such as tramadol, codeine and diazepam the period of stay or three months, whichever is less, and says a medicine missing from it may still be covered by the law.
Two other official sources say approval is needed first. The UK Foreign, Commonwealth and Development Office says you will need approval from the UAE authorities to bring in medication the UAE classes as narcotic, psychotropic, controlled or semi-controlled, that you must get approval in advance from the UAE Ministry of Health, that without evidence of it the medication will not be allowed into the UAE, and that visitors may bring up to 3 months’ supply, reduced to one month for medication on the list requiring approval. The UAE Embassy in the United States says all travellers carrying controlled medication into the UAE must apply for approval through the Ministry of Health website, which it says should be done before the trip, and that other prescription medication and over-the-counter medication need no prior approval.
FCDO via GOV.UK, United Arab Emirates travel advice, entry requirements Checked 2026-10-02.
Read directly on 2 October 2026; updated 24 July 2026. Written for UK visitors; it does not address UAE residents. Its link for applying goes to the Emirates Drug Establishment page that calls the service optional. It says applications are normally processed within 5 working days; the Establishment says 1 working day.
Embassy of the United Arab Emirates in the United States, page on permitted prescription drugs when entering the UAE Checked 2026-10-02.
Read directly on 2 October 2026. The page carries no content date and still points to the Ministry of Health and Prevention, which, by its own archived page, handed the service to the Emirates Drug Establishment on 29 December 2025.
The FCDO writes for visitors. The Establishment calls approval optional for visiting travellers, and for residents says the application must be submitted through its electronic system, though it describes that service as importing through shipping companies. The embassy’s page still points to the Ministry of Health and Prevention. If you live in the UAE, ask the Establishment in writing before you fly.
Ask the authority behind your row, in writing and before you travel, and keep its reply with your medicines.
Short answers
Asked before packing, and after discharge.
Is tramadol on India's NDPS lists?
On the list we read, yes. India’s list of psychotropic substances names tramadol, added by a later notification. That list decides the question, and this page only reports it; your prescriber or the hospital pharmacist can confirm what your tablets contain. Leaving India with it brings in the export rule and the gap described above, then your own country’s row in the table.
What about the ordinary tablets I take every day?
India’s drug regulator describes a baggage allowance for small quantities of drugs, set out above, but no official Indian text we read defines the average dose it is counted in or explains how it applies to a particular medicine, and none sets a prescription rule for ordinary medicines. For questions about prohibited or restricted goods, the CBIC traveller guide, which says it carries no legal authority, points to the Customs Help Desk in the arrival hall.
I've been given tablets at discharge that I don't recognise. Who can tell me what they are?
Ask before you leave the hospital. Its pharmacist can tell you what each tablet contains, and your discharge letter is the paper to check the names against. Once you know the ingredient, India’s lists and your own country’s row in the table above show which rules to read next.
Weeks before you fly, find out whether we are the right people for your case.
We use the free 30 minute consultation to work out with you whether we can help, and to tell you whether an independent opinion would help you, or whether it would not. Please hold back records and scans until after we have talked; anything clinical comes later, through a secure link we send you.
